[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-353408-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-353408-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","delineating-swisnf-gene-and-subtype-expression-in-cancer","Delineating SWI/SNF gene and subtype expression in cancer","","Approximately 20% of human cancers carry mutations in SWI/SNF chromatin remodeling genes, which form three main subtypes: cBAF, PBAF, and GBAF. SWI/SNF mutations may alter chromatin remodeling and epigenetic regulation, but subtype- and tumor type–specific expression patterns remain insufficiently characterized. This study profiles all 29 SWI/SNF genes across 33 tumor types (~11,000 TCGA samples). Results identify tumor-type variability, modest expression effects from mutations, and downstream transcriptional program changes linked to epigenetic regulation, supporting biomarker and targeted-therapy development.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/delineating-swisnf-gene-and-subtype-expression-in-cancer/353408/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/delineating-swisnf-gene-and-subtype-expression-in-cancer/353408.png","ImageObject",300,407,{"name":42,"@type":43},"hdkawk","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-18","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What proportion of cancers involve mutations in SWI/SNF genes?","Question",{"text":63,"@type":64},"About 20% of all human cancers contain mutations in genes encoding components of the SWI/SNF chromatin remodeling complex.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was SWI/SNF gene expression analyzed in this study?",{"text":68,"@type":64},"Expression levels of all 29 SWI/SNF genes were profiled across 33 tumor types using DNA and mRNA data from The Cancer Genome Atlas, comprising approximately 11,000 samples.",{"name":70,"@type":61,"acceptedAnswer":71},"Do SWI/SNF gene mutations strongly change SWI/SNF gene expression levels?",{"text":72,"@type":64},"Mutations in SWI/SNF genes result in only minor changes in SWI/SNF gene expression levels, but they are associated with downstream regulation of transcriptional programs linked to epigenetic regulation.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},353408,1790439302,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},3985747859855,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Canfjorden etal. Epigenetics & Chromatin (2026) 19:35 Epigenetics & Chromatin  \n[https://doi.org/10.1186/s13072-026-00696-9](https://doi.org/10.1186/s13072-026-00696-9)  \nRESEARCH Open Access  \nDelineating SWI/SNF gene and subtype expression in cancer  \nVilma Canfjorden1, Malin Lindén1,2, Tobias Österlund1,2,3, Erik Larsson4 and Anders Ståhlberg1,2,3,5*  \nAbstract  \nBackground Approximately 20% of all cancers contain mutations in genes coding for components of the SWI/SNF chromatin remodeling complex, which exists in three main subtypes: cBAF, PBAF, and GBAF. Mutations in SWI/SNF genes may disrupt chromatin remodeling and deregulate epigenetic processes, leading to aberrant gene expression profiles. However, the gene expression profiles of SWI/SNF genes and subtypes across different tumor types in relation to SWI/SNF mutations remain poorly understood.  \nResults In this study, we profile the expression levels of all 29 SWI/SNF genes in 33 tumor types using DNA and mRNA data from The Cancer Genome Atlas, comprising approximately 11,000 samples. We find that ACTL6B, DPF1, DPF3 and SMARCD3 vary the most among tumor types and that 10 out of 33 tumor types show distinct SWI/SNF gene expression signatures. The SWI/SNF gene expression in tumors are partly influenced by their tissue of origin. Furthermore, the mean expression levels of SWI/SNF subtype-specific genes are overall similar between tumor types, with higher variations in cBAF compared to PBAF and GBAF. Mutations in SWI/SNF genes result in only minor changes in SWI/SNF gene expression levels but are associated with downstream regulation of transcriptional programs linked to epigenetic regulation, especially in colon adenocarcinoma, kidney renal clear cell carcinoma, stomach adenocarcinoma and uterine corpus endometrial carcinoma.  \nConclusions Our study provides insights into SWI/SNF gene and subtype expression in cancer, which may contribute to the development of biomarkers and targeted therapies.  \nKeywords Cancer, cBAF, GBAF, Gene expression, PBAF, SWI/SNF, TCGA  \n*Correspondence:  \nAnders Ståhlberg  \n[anders.stahlberg@gu.se](anders.stahlberg@gu.se)  \n1Department of Laboratory Medicine, Sahlgrenska Center for Cancer Research, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, 413 90 Gothenburg, Sweden  \n2Department of Clinical Genetics and Genomics, Sahlgrenska University Hospital, Region Västra Götaland, 413 45 Gothenburg, Sweden 3Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, 413 90 Gothenburg, Sweden  \n4Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg,  \n413 90 Gothenburg, Sweden  \n5Science for Life Laboratory, Institute of Biomedicine, University of Gothenburg, 413 90 Gothenburg, Sweden  \nBackground  \nCancer typically develops through mutations in oncogenes or tumor suppressor genes but can occur through different oncogenic mechanisms including but not limited to copy number alterations, chromosomal rearrangement, epigenetic mechanisms and viral oncogenesis. In the last decades, the importance of epigenetic processes in cancer development has become increasingly recognized [1]. Specifically, the SWItch/Sucrose Non-Fermentable (SWI/SNF) genes have been found to be frequently mutated in numerous cancer types, occurring in about 20% of all human cancers [2, 3]. The SWI/SNF chromatin remodeling complex utilizes energy from ATP hydrolysis  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indic","cbCaigSjyuB7FRnl","https://ap.wps.com/l/cbCaigSjyuB7FRnl","pdf",6893519,17,"English","# Abstract\n## Background\n## Results\n## Conclusions\n# Introduction\n## Epigenetic mechanisms in cancer\n## SWI/SNF genes and mutations\n# Figures\n## Expression patterns across tumor types","[{\"question\":\"What proportion of cancers involve mutations in SWI/SNF genes?\",\"answer\":\"About 20% of all human cancers contain mutations in genes encoding components of the SWI/SNF chromatin remodeling complex.\"},{\"question\":\"How was SWI/SNF gene expression analyzed in this study?\",\"answer\":\"Expression levels of all 29 SWI/SNF genes were profiled across 33 tumor types using DNA and mRNA data from The Cancer Genome Atlas, comprising approximately 11,000 samples.\"},{\"question\":\"Do SWI/SNF gene mutations strongly change SWI/SNF gene expression levels?\",\"answer\":\"Mutations in SWI/SNF genes result in only minor changes in SWI/SNF gene expression levels, but they are associated with downstream regulation of transcriptional programs linked to epigenetic regulation.\"}]","Delineating SWI/SNF gene and subtype expression in cancer | PDF",1790105176,43,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/508c004c0f8b2a8a5ac1169831533cf1.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/386c79b2cf757b77f40ae9d1b4edc1d3.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/97b01511ab996db5ae5a0bee7953b20d.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bc1e3680bdb165ee8b97e6665aeb70e7.webp",980,1306]